US Patent 7060694 High potency dihydroergotamine compositions
Patent 7060694 was granted and assigned to Pozen on June, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Nov, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+364 characters)
Article
Patent abstract
The present invention is directed to improved formulations for dihydroergotamine in which the drug is present at a concentration of at least 2.9 mM. The invention encompasses methods for using these formulations in treating patients for migraine headaches and the packaging of formulation into prefilled syringes for self-administration by patients.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Donna Gilbert0
John R. Plachetka0
Date of Patent
June 13, 2006
0Patent Application Number
102819820
Date Filed
October 29, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7060694 High potency dihydroergotamine compositions
Find more entities like US Patent 7060694 High potency dihydroergotamine compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
